Hera Biotech

Hera Biotech is revolutionizing women's health through innovative diagnostic tools for endometriosis, a debilitating condition that affects millions of women worldwide. Their primary focus is on developing non-invasive tests for the early diagnosis and staging of endometriosis. Hera Biotech's lead product, MetriDx™, is a groundbreaking, non-surgical test for endometriosis. This innovative approach utilizes gene expression analysis of endometrial cells obtained through a minimally invasive procedure. By analyzing thousands of data points, MetriDx™ can provide an early, definitive diagnosis and accurate staging of endometriosis.

Jobs: